Ropivacaine 2 % — Competitive Intelligence Brief

Ropivacaine 2 % (Ropivacaine 2 %) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Ropivacaine 2 % (Ropivacaine 2 %) — Hospital Ambroise Paré Paris. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ropivacaine 2 % TARGET	Ropivacaine 2 %	Hospital Ambroise Paré Paris	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Bupivacaine FNB	Bupivacaine FNB	Pacira Pharmaceuticals, Inc	marketed	Local anesthetic	Voltage-gated sodium channels
Regular bupivacaine	Regular bupivacaine	Vanderbilt University Medical Center	marketed	Local anesthetic	Voltage-gated sodium channels
Bupivacaine %0.25 (isobaric)	Bupivacaine %0.25 (isobaric)	Bursa City Hospital	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Standard dose topiramate	Standard dose topiramate	Mario Negri Institute for Pharmacological Research	marketed	Anticonvulsant / Antiepileptic agent	Voltage-gated sodium channels, GABA-A receptors, carbonic anhydrase
Bupivacain (Postoperative)	Bupivacain (Postoperative)	Başakşehir Çam & Sakura City Hospital	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
LD: Lidocaine and dexamethasone	LD: Lidocaine and dexamethasone	B.P. Koirala Institute of Health Sciences	marketed	Local anesthetic with corticosteroid combination	Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

1. Poznan University of Medical Sciences · 4 drugs in this class
2. Nantes University Hospital · 3 drugs in this class
3. Bozyaka Training and Research Hospital · 2 drugs in this class
4. ASST Gaetano Pini-CTO · 2 drugs in this class
5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
6. Chiang Mai University · 1 drug in this class
7. Beijing Tiantan Hospital · 1 drug in this class
8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
10. China Medical University, China · 1 drug in this class